Allogeneic stem cell therapy (Stematix)

N/A

Report date: 2023/02/17 21:06:05

Base Information

Drug NameAllogeneic stem cell therapy (Stematix)
Drug Alias NameAllostrome
ClassificationCell and gene therapy > Cell therapy > Stem cell therapyCell and gene therapy > Cell therapy > Donor > Autologous
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsMyocardial InfarctionJoint DiseasesCartilage Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesStematix
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBago
Active IndicationsN/A
Inactive IndicationsMyocardial InfarctionJoint DiseasesCartilage Diseases

Other Information

ATC CodeN/A
Related LinksN/A